Inventor
FELDER EVA
DE24 patents
⚠️ This page may combine multiple inventors who share the name “FELDER EVA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BAVARIAN NORDIC AS
11 patentsUS7445924B2Nov 4, 2008
Modified Vaccinia Ankara virus variant and cultivation method
BAVARIAN NORDIC AS63 citations97
US7964398B2Jun 21, 2011
Modified vaccinia ankara virus variant and cultivation method
BAVARIAN NORDIC AS28 citations96
US7964395B2Jun 21, 2011
Modified vaccinia ankara virus variant and cultivation method
BAVARIAN NORDIC AS30 citations96
US7964396B2Jun 21, 2011
Modified vaccinia ankara virus variant and cultivation method
BAVARIAN NORDIC AS30 citations96
US8029800B2Oct 4, 2011
Recombinant modified vaccinia virus ankara (MVA) comprising human immunodeficiency virus (HIV) genes inserted into one or more intergenic regions (IGRs)
BAVARIAN NORDIC AS12 citations92
US8021669B2Sep 20, 2011
Methods for inducing an immune response in a host comprising administering modified vaccinia virus ankara (MVA) recombinants comprising human immunodeficiency virus (HIV) genes inserted into one or more intergenic regions (IGRs)
BAVARIAN NORDIC AS21 citations92
US7695939B2Apr 13, 2010
Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
BAVARIAN NORDIC AS15 citations92
US7501127B2Mar 10, 2009
Intergenic regions as novel sites for insertion of HIV DNA sequences in the genome of Modified Vaccinia virus Ankara
BAVARIAN NORDIC AS26 citations92
US7569228B2Aug 4, 2009
Fusion proteins of non-attenuated HIV regulatory/accessory proteins
BAVARIAN NORDIC AS13 citations89
US7964397B2Jun 21, 2011
Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
BAVARIAN NORDIC AS6 citations73
US8673318B2Mar 18, 2014
Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
BAVARIAN NORDIC AS0 citations51
HOWLEY PAUL
9 patentsUS8309098B2Nov 13, 2012
Recombinant modified vaccinia ankara (MVA) virus containing heterologous DNA inserts encoding human immunodeficiency virus (HIV) antigens inserted into one or more intergenic regions (IGRs)
HOWLEY PAUL33 citations96
US8197822B2Jun 12, 2012
Method for the production of human immunodeficiency virus (HIV) proteins utilizing modified vaccinia virus ankara (MVA) recombinants comprising HIV genes inserted into one or more intergenic regions (IGRs)
HOWLEY PAUL6 citations84
US8143054B2Mar 27, 2012
Fusion protein of HIV regulatory/accessory proteins
HOWLEY PAUL7 citations84
US8323661B2Dec 4, 2012
Method for generating a stable recombinant modified vaccinia virus ankara (MVA) comprising human immunodeficiency virus (HIV) genes inserted into one or more intergenic regions (IGRs)
HOWLEY PAUL3 citations74
US8198088B2Jun 12, 2012
Method for introducing human immunodeficiency virus nucleotide sequences into a cell utilizing modified vaccinia virus Ankara (MVA) recombinants comprising HIV genes inserted into one or more intergenic regions (IGRs)
HOWLEY PAUL5 citations74
US8147839B2Apr 3, 2012
Fusion proteins of HIV regulatory/accessory proteins
HOWLEY PAUL2 citations63
US8137931B2Mar 20, 2012
Fusion proteins of HIV regulatory/accessory proteins
HOWLEY PAUL2 citations63
US8435535B2May 7, 2013
Fusion proteins of HIV regulatory/accessory proteins
HOWLEY PAUL0 citations52
US8389275B2Mar 5, 2013
Fusion proteins of HIV regulatory/accessory proteins
HOWLEY PAUL0 citations52